What Eyecelerator does

Eyecelerator is a private, conference-and-content platform focused exclusively on ophthalmology innovation, structured as a program of the American Academy of Ophthalmology (AAO). The company organizes next-generation business conferences co-located with AAO and ARVO annual meetings, featuring key opinion leader (KOL)-driven programs on translational research, clinical development, manufacturing, regulatory strategy, and market access. Presenting companies—curated by an Eyecelerator Program Committee of seasoned ophthalmic professionals—pitch from stage to an audience of investors, physicians, and industry leaders, with 40 companies presenting at the ARVO 2026 event across three simultaneous breakout rooms and presentation video remaining on the Eyecelerator website for one year. The Eye to Market web series, produced with Unither Pharmaceuticals and Ora, extends the platform into on-demand digital content distributed via YouTube and partner channels.

The core technology is therefore event curation and content distribution rather than software: it consists of a Program Committee vetting pipeline, a tiered sponsorship stack (Palladium at $115,000 full-year down to Bronze at $15,000 full-year), a presenting-company application and selection workflow ($5,000 per meeting, waived for sponsors), and a tiered attendee registration model ($750 general / $425 AAO–ARVO members / $75 in training). Commercial reach currently sits within the United States, anchored by flagship sponsor relationships with Alcon, Astellas, AbbVie, Ocular Therapeutix, Regeneron, Bausch & Lomb, Johnson & Johnson Vision, and Adverum/Eli Lilly, alongside co-founder Gil Kliman, MD's affiliation with $2B AUM InterWest Partners as a structural channel into ophthalmology venture capital.

Eyecelerator's customer base spans four primary segments: ophthalmology entrepreneurs seeking capital and visibility, ophthalmology-focused investors seeking curated deal flow, physician KOLs serving on program committees and moderating sessions, and pharma/medtech companies purchasing sponsorship for brand positioning and early access to emerging technologies. The company is governed by California law, headquartered at 655 Beach Street in San Francisco, and operates as a private entity without disclosed funding rounds, revenue figures, or ownership percentages, with AAO functioning as the parent/partner organization and Stephen D. McLeod, MD (AAO CEO) on the board.

Name

Eyecelerator

Legal name

Eyecelerator

Website

https://eyecelerator.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Eyecelerator is a private ophthalmology innovation platform, operated as a program of the American Academy of Ophthalmology, that runs curated business conferences at AAO and ARVO meetings and the Eye to Market web series, connecting ophthalmology entrepreneurs, investors, physicians, and pharma/medtech sponsors.

Ownership category

akta.pro rank

Product category

Ophthalmology Innovation Conferences

NAICS

Convention and Trade Show Organizers (561920), Convention and Trade Show Organizers (56192)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Professional & Association Conferences (MPAGAGAB)

akta.pro secondary industries

Conferences & Conventions Operations Services (Registration, AV, Logistics) (MPAGAGAM), Healthcare, Medical Devices & Pharma Shows Organizers (THAHABAH), Training, Workshops & Certification Events (MPAGAGAJ)

Keywords

• Ophthalmology innovation events
• Medical conference services
• Healthcare venture networking
• Eye care investment platform
• KOL ophthalmology meetings

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Sponsorship Revenue: Eyecelerator generates revenue through tiered sponsorship packages (Palladium, Platinum, Gold, Bronze) with pricing ranging from $10,000 for one-meeting Bronze sponsorship to $115,000 for full-year Palladium sponsorship. Sponsors receive benefits including passes, logo placement, networking opportunities, and speaking slots.
2. Presenting Company Fees: Companies selected to present from stage pay a $5,000 fee per meeting. Benefits include networking location, presentation featured on website, and 2 free passes. Sponsors who apply and are selected have this fee waived.
3. Conference Registration Fees: Revenue from attendee registration fees at live conferences. Eyecelerator @ Park City charged $750 for general attendees, $425 for ARVO/AAO members, and $75 for those in training.
4. Eye to Market Web Series: Content series developed in collaboration with Unither Pharmaceuticals and Ora, distributed via Eyecelerator YouTube channel and shared across partner channels, providing brand exposure and thought leadership opportunities.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Eyecelerator organizes and hosts next-generation business conferences at major ophthalmology industry meetings, including AAO (American Academy of Ophthalmology) and ARVO (Association for Research in Vision and Ophthalmology), featuring KOL-driven programs, presenting company showcases, and curated networking. It complements live events with the "Eye to Market" web series that explores ophthalmic innovation from research to patient adoption. The platform connects ophthalmology entrepreneurs, investors, physicians, and industry leaders through sponsorship, presenting company slots, and attendee registration.

Product overview

Eyecelerator is a conference and event company focused on ophthalmology innovation. The core offering consists of Eyecelerator Conferences held at major ophthalmology meetings (AAO, ARVO, and standalone events), where the company organizes KOL-driven programs featuring industry advancements, investment trends, and innovative products. Supporting offerings include the 'Eye to Market' web series (produced in partnership with Ora and Unither Pharmaceuticals) and the Presenting Company Showcase program where selected companies present novel clinical treatments and emerging technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• Eyecelerator Conferences Full-day, KOL-driven business conferences held at AAO and ARVO annual meetings (e.g., Eyecelerator @ AAO 2026 on Oct. 8 in New Orleans, ARVO 2026, Eyecelerator @ Park City). Each event features presenting company showcases across three simultaneous breakout rooms, expert panels on industry advancements and investment trends, and networking sessions. Designed for ophthalmology entrepreneurs, investors, physicians, and industry leaders.
• Eye to Market Web Series A web video series developed with Unither Pharmaceuticals and Ora that explores how ophthalmic innovations move from concept to patient care, featuring expert interviews on translational research, clinical development, manufacturing, regulatory strategy, and market access. Episodes are published on the Eyecelerator YouTube channel and shared across partner channels, targeting innovators, clinicians, investors, manufacturers, and industry leaders globally.

Quantifiable outcome

• 40 companies present at ARVO 2026 across three simultaneous breakout rooms
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• American Academy of OphthalmologycoreStrategic or Co-development PartnerThe American Academy of Ophthalmology is Eyecelerator's program partner. AAO is the world's largest association of eye physicians and surgeons with 32,000 members. Eyecelerator is brought to you by AAO, which protects sight and empowers lives by setting standards for ophthalmic education and advocating for patients and the public.
• Unither PharmaceuticalsflagshipGTM or Marketing PartnerEyecelerator announced collaboration with Unither Pharmaceuticals and Ora to launch 'Eye to Market,' a new web series exploring how ophthalmic innovations move from scientific development to real-world patient adoption. The series features expert interviews covering topics including translational research, clinical development, manufacturing, regulatory strategy, and market access.
• Ora, Inc.flagshipGTM or Marketing PartnerEyecelerator collaboration with Ora, Inc. and Unither Pharmaceuticals on 'Eye to Market' web series. Ora is a major ophthalmology contract research organization. Episodes published on Eyecelerator YouTube channel and shared across partner channels targeting innovators, clinicians, investors, manufacturers, and industry leaders.

Scale indicators4 records

Expansion highlights4 records

Direct peers

• Ophthalmology Innovation Summit (OIS): Predecessor and closest direct competitor to Eyecelerator — a conference series convening ophthalmology entrepreneurs, clinicians, and investors to showcase emerging companies and technologies.
• Biotech Showcase: Investor and partnering conference held alongside the J.P. Morgan Healthcare Conference where emerging biotech and medtech companies present to investors — same presenting-company + sponsor + investor model as Eyecelerator.
• RESI Conference (Redefining Early Stage Investments): Life-sciences early-stage investor conference series featuring presenting companies and panel-driven programming for entrepreneurs and investors — directly comparable event format and target audience.

Broad incumbents

• BIO International Convention: Largest global biotech partnering event operated by the Biotechnology Innovation Organization; competes for the same enterprise sponsors and presenting-company dollars across all therapeutic areas including ophthalmology.
• J.P. Morgan Healthcare Conference: The flagship annual healthcare investment conference that draws presenting biotechs, medtechs, and investors — a major competitor for sponsor mindshare and presenting-company visibility in healthcare.
• AAO Annual Meeting (American Academy of Ophthalmology): The parent organization's own flagship clinical meeting — provides the distribution and audience pipeline that Eyecelerator leverages, and is the platform's largest adjacent clinical event.
• ARVO Annual Meeting (Association for Research in Vision and Ophthalmology): Premier vision-research conference where Eyecelerator co-locates its innovation programming — competing adjacent event with overlapping scientific and KOL audiences.
• ASCRS Annual Meeting (American Society of Cataract and Refractive Surgery): Major ophthalmic surgeon society meeting with its own industry programming, exhibits, and innovation sessions that compete for sponsor and presenter attention in the ophthalmology space.

Emerging players

• MedCity INVEST: Healthcare investor conference series with themed tracks (including medical devices) and presenting-company showcases — comparable emerging format targeting a similar investor/entrepreneur audience.

Regional players

• BIO-Europe: Europe's largest biotech partnering conference — comparable presenting-company and sponsor model but focused on European life sciences, complementing Eyecelerator's US-centric footprint.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/eyecelerator
• YouTubeyoutube.com/@eyecelerator
• LinkedInlinkedin.com/company/eyecelerator

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eyecelerator